Efficacy of Intralesional Sodium Thiosulfate Versus Intralesional Saline for Dystrophic and Idiopathic Calcinosis Cutis

Stopped early · Phase 4

Conditions studied: Calcinosis Cutis

In brief

The purpose of our research is to compare the effectiveness of 125mg/50ml sodium thiosulfate (STS) solution to normal saline (0.9% sodium chloride) when injected intralesionally for the treatment of calcinosis cutis. Our specific aim is to assess the response of dystrophic and idiopathic calcinosis cutis to the injections of sodium thiosulfate in our patients.

Key facts

Study ID

NCT03639779

Run by

University of Central Florida

People needed

5

Starts

2018-11-02

Expected to finish

2019-12-31

Last updated by the study team

2021-07-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female adult 18 years of age or older
• Must have health insurance will be eligible to participate
• Must have a current diagnosis of dystrophic or idiopathic calcinosis cutis
• Subjects must have at least 2 lesions of at least 2mm in size

You may not qualify if…

• Unable to read and speak English
• Allergy to any component of the sodium thiosulfate solution
• Adults unable to consent
• Individuals who are not yet adults (infants, children, teenagers)
• Pregnant women
• Women who are breastfeeding
• Prisoners

Where it is running

• UCF Health Lake Nona Office — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.